Loading...
7 Circulatory System Drugs Reports
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Novartis AG , Bristol-Myers Squibb, Incyte Corporation, Takeda Pharmaceutical Company Limited, Viatris (Mylan N.V.)
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Bayer AG, Gilead Sciences, Inc., Johnson & Johnson (Actelion Pharmaceuticals, Ltd.), Pfizer, Inc., United Therapeutics Corporation
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Pfizer Inc., AstraZeneca, Merck & Co., Inc. , Amgen Inc., Regeneron Pharmaceuticals, Inc.
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America, Global
Major Players: Cardinal Health, Stryker, Boston Scientific Corporation, Edward Lifesciences, AngioDynamics
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Boehringer Ingelheim GmbH, Johnson & Johnson, Sanofi SA, Pfizer Inc., Laurus Lab (Aspen Pharmacare Holdings Limited)
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Pfizer, Inc., F. Hoffmann-LA Roche ltd, AbbVie, Inc., Bristol-Myers Squibb Company, Sanofi S.A
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Takeda Pharmaceutical Company Limited (Shire Plc) , Sanofi, Novo Nordisk A/S, CSL Ltd, Pfizer Inc
Filter Reports
By Region
By Countries
